Solara Active Pharma Sciences inks pact with SeQuent Scientific

24 Sep 2018 Evaluate

Solara Active Pharma Sciences has entered into a business transfer agreement with SeQuent Scientific for sale of API facility at Mahad. The total consideration for the unit would be Rs 46.40 crore. The company has decided to hive-off Mahad unit as it is not aligned to multi product and US focused business of the company.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

462.40 1.30 (0.28%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×